Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): A randomised, open-label, phase 3 trial
Manfred Westphal*, Seppo Ylä-Herttuala, John Martin, Peter Warnke, Philippe Menei, David Eckland, Judith Kinley, Richard Kay, Zvi Ram
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): A randomised, open-label, phase 3 trial'. Together they form a unique fingerprint.